Clinical Trial Update: A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial completed evaluating Ultrashort PRS Regimen V for treating multidrug-resistant tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis

Drugs mentioned

• Ultrashort PRS Regimen V

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: MDR-TB | Phase 4 | Status: COMPLETED